CASE REPORT
A case of an 11-year-old boy with paediatric inflammatory multisystem syndrome associated with coronavirus disease, haemophagocytic lymphohistiocytosis, and systemic juvenile idiopathic arthritis
 
More details
Hide details
1
Department of Pediatrics and Pediatric Endocrinology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland
 
2
Department of Oncology, Haematology and Chemotherapy, Upper Silesia Children’s Care Health Centre, Katowice, Poland
 
3
Department of Paediatrics, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland
 
4
Department of Rheumatology, The Paediatric Centre in Sosnowiec, Poland
 
5
Department of Gastroenterology, Department of Paediatrics, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland
 
 
Submission date: 2023-12-05
 
 
Final revision date: 2024-01-09
 
 
Acceptance date: 2024-01-14
 
 
Publication date: 2024-06-27
 
 
Corresponding author
Ewa Błaszczyk
Ewa Błaszczyk, Department of Paediatrics and Paediatric Endocrinology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland
 
 
Pediatr Pol 2024;99(2):167-174
 
KEYWORDS
TOPICS
ABSTRACT
After the announcement of the coronavirus disease 2019 (COVID-19) pandemic, a new disease connected with SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection was described: paediatric multisystem inflammatory syndrome associated with coronavirus disease (PIMS). PIMS is an acute and potentially dangerous inflammatory syndrome that may lead to cardiac complications. It requires differential diagnosis with Kawasaki disease. Some patients with PIMS can develop macrophage activation syndrome (MAS), which until now has occurred most commonly with systemic-onset juvenile idiopathic arthritis (JIA) and is closely related to haemophagocytic lymphohistiocytosis (HLH). In this article we present a case report of a patient with diagnosed PIMS, including PIMS with MAS, and with later diagnosis of HLH and JIA.
REFERENCES (16)
1.
COVID live update: 180,330,762 cases and 3,906,246 deaths from the coronavirus – worldometer. Available from: https://www.worldometers.info/....
 
2.
Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet (London, England) 2020; 395: 1607.
 
3.
Whittaker E, Bamford A, Kenny J, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA 2020; 324: 259.
 
4.
McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 2017; 135: e927-99.
 
5.
Henderson LA, Canna SW, Friedman KG, et al. American College of Rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 2. Arthritis Rheumatol 2021; 73: e13-29.
 
6.
Grom AA, Mellins ED. Macrophage activation syndrome: advances towards understanding pathogenesis. Curr Opin Rheumatol 2010; 22: 561.
 
7.
Okarska-Napierała M, Ludwikowska K, Jackowska T, et al. Postępowanie z dzieckiem z wieloukładowym zespołem zapalnym powiązanym z Covid-19 approach to a child with paediatric inflammatory. Przeg Pediat 2020; 49: 1-9.
 
8.
Henter JI, Horne AC, Aricó M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 124-131.
 
9.
Petty RE, Southwood TR, Manners P, et al. International league of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31: 390-392.
 
10.
Godfred-Cato S, Bryant B, Leung J, et al. COVID-19 – Associated multisystem inflammatory syndrome in children – United States, March – July 2020. Morb Mortal Wkly Rep 2020; 69: 1074.
 
11.
Centers for Disease Control and Prevention. COVID Data Tracker. Atlanta, GA: U.S. Departament of Health and Human Services, CDC; 2023 September 18. CDC COVID Data Tracker: Home. Available from: https://covid.cdc.gov/covid-da....
 
12.
Royal College of Paediatrics and Child Health. Guidance: Paediatric multisystem inflammatory syndrome temporallly associated with Cov-19. R Coll Paediatr Child Heal 2020; 1-6.
 
13.
Pawar SM. Multi system inflammatory syndrome in children and adolescents temporally related to COVID-19. GFNPSS-International J Multidiscip Res 2020; 1: 97.
 
14.
Ravelli A, Minoia F, Davì S, et al. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: a European League against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborat. Arthritis Rheumatol (Hoboken, NJ) 2016; 68: 566-576.
 
15.
Malinowska I, Machaczka M, Popko K, Siwicka A, Salamonowicz M, Nasiłowska-Adamska B. Hemophagocytic syndrome in children and adults. Arch Immunol Ther Exp (Warsz) 2014; 62: 385-394.
 
16.
Retamozo S, Brito-Zerón P, Sisó-Almirall A, Flores-Chávez A, Soto- Cárdenas MJ, Ramos-Casals M. Haemophagocytic syndrome and COVID-19. Clin Rheumatol 2021; 40: 1233.
 
Journals System - logo
Scroll to top